Immunovant, Inc.
IMVT · Healthcare · $7.0B
$34.27+1.44%
Price
$38.79
$34.00
Jul 2, 26Oct 1, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$7M0.0%
6/'26 vs prev quarter
Company Health
Market Cap$7.0B
Operating Margin-7877.5%
Cash on Hand$798M11.4% of market cap
Free Cash Flow$-414M-5.9% of market cap
Among 327 Biotechnology peers
LowMedianHigh
PSR982.7xmedian 11.7xPBR9.5xmedian 2.1xROE-73.2%median -54.5%
